KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Other Operating Expenses (2019 - 2025)

Castle Biosciences' Other Operating Expenses history spans 7 years, with the latest figure at $20.6 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses changed 0.33% year-over-year to $20.6 million; the TTM value through Dec 2025 reached $105.9 million, up 48.46%, while the annual FY2025 figure was $105.9 million, 48.46% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $20.6 million at Castle Biosciences, down from $21.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $44.7 million in Q1 2025 and bottomed at -$10.6 million in Q2 2022.
  • The 5-year median for Other Operating Expenses is $13.6 million (2023), against an average of $14.1 million.
  • The largest annual shift saw Other Operating Expenses skyrocketed 1397.35% in 2021 before it tumbled 368.53% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $5.6 million in 2021, then skyrocketed by 104.01% to $11.4 million in 2022, then grew by 28.5% to $14.7 million in 2023, then skyrocketed by 39.67% to $20.5 million in 2024, then rose by 0.33% to $20.6 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Other Operating Expenses are $20.6 million (Q4 2025), $21.0 million (Q3 2025), and $19.6 million (Q2 2025).